These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 34546748)

  • 1. Discovery of New 4-Indolyl Quinazoline Derivatives as Highly Potent and Orally Bioavailable P-Glycoprotein Inhibitors.
    Yuan S; Wang B; Dai QQ; Zhang XN; Zhang JY; Zuo JH; Liu H; Chen ZS; Li GB; Wang S; Liu HM; Yu B
    J Med Chem; 2021 Oct; 64(19):14895-14911. PubMed ID: 34546748
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immuno-oncology agent IPI-549 is a modulator of P-glycoprotein (P-gp, MDR1, ABCB1)-mediated multidrug resistance (MDR) in cancer: In vitro and in vivo.
    De Vera AA; Gupta P; Lei Z; Liao D; Narayanan S; Teng Q; Reznik SE; Chen ZS
    Cancer Lett; 2019 Feb; 442():91-103. PubMed ID: 30391357
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discovery of 5-Cyano-6-phenylpyrimidin Derivatives Containing an Acylurea Moiety as Orally Bioavailable Reversal Agents against P-Glycoprotein-Mediated Mutidrug Resistance.
    Wang B; Ma LY; Wang JQ; Lei ZN; Gupta P; Zhao YD; Li ZH; Liu Y; Zhang XH; Li YN; Zhao B; Chen ZS; Liu HM
    J Med Chem; 2018 Jul; 61(14):5988-6001. PubMed ID: 29975529
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discovery of the Triazolo[1,5-
    Wang S; Wang SQ; Teng QX; Lei ZN; Chen ZS; Chen XB; Liu HM; Yu B
    J Med Chem; 2021 Nov; 64(21):16187-16204. PubMed ID: 34723530
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lapatinib (Tykerb, GW572016) reverses multidrug resistance in cancer cells by inhibiting the activity of ATP-binding cassette subfamily B member 1 and G member 2.
    Dai CL; Tiwari AK; Wu CP; Su XD; Wang SR; Liu DG; Ashby CR; Huang Y; Robey RW; Liang YJ; Chen LM; Shi CJ; Ambudkar SV; Chen ZS; Fu LW
    Cancer Res; 2008 Oct; 68(19):7905-14. PubMed ID: 18829547
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design, synthesis, and discovery of ocotillol-type amide derivatives as orally available modulators of P-glycoprotein-mediated multidrug resistance.
    Ren Q; Yang G; Guo M; Guo J; Li Y; Lu J; Yang Q; Tang H; Li Y; Fang X; Sun Y; Qi JG; Tian J; Wang H
    Eur J Med Chem; 2019 Jan; 161():118-130. PubMed ID: 30347326
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure-Based Design, Synthesis, and Biological Evaluation of New Triazolo[1,5-
    Wang S; Wang SQ; Teng QX; Yang L; Lei ZN; Yuan XH; Huo JF; Chen XB; Wang M; Yu B; Chen ZS; Liu HM
    J Med Chem; 2020 Dec; 63(24):15979-15996. PubMed ID: 33280384
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Marine sponge-derived sipholane triterpenoids reverse P-glycoprotein (ABCB1)-mediated multidrug resistance in cancer cells.
    Abraham I; Jain S; Wu CP; Khanfar MA; Kuang Y; Dai CL; Shi Z; Chen X; Fu L; Ambudkar SV; El Sayed K; Chen ZS
    Biochem Pharmacol; 2010 Nov; 80(10):1497-506. PubMed ID: 20696137
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulation of the spacer in N,N-bis(alkanol)amine aryl ester heterodimers led to the discovery of a series of highly potent P-glycoprotein-based multidrug resistance (MDR) modulators.
    Dei S; Braconi L; Trezza A; Menicatti M; Contino M; Coronnello M; Chiaramonte N; Manetti D; Perrone MG; Romanelli MN; Udomtanakunchai C; Colabufo NA; Bartolucci G; Spiga O; Salerno M; Teodori E
    Eur J Med Chem; 2019 Jun; 172():71-94. PubMed ID: 30947123
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sensitization of ABCB1 overexpressing cells to chemotherapeutic agents by FG020326 via binding to ABCB1 and inhibiting its function.
    Dai CL; Liang YJ; Chen LM; Zhang X; Deng WJ; Su XD; Shi Z; Wu CP; Ashby CR; Akiyama S; Ambudkar SV; Chen ZS; Fu LW
    Biochem Pharmacol; 2009 Aug; 78(4):355-64. PubMed ID: 19410561
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel Heat Shock Protein 90 Inhibitors Suppress P-Glycoprotein Activity and Overcome Multidrug Resistance in Cancer Cells.
    Dinić J; Podolski-Renić A; Jovanović M; Musso L; Tsakovska I; Pajeva I; Dallavalle S; Pešić M
    Int J Mol Sci; 2019 Sep; 20(18):. PubMed ID: 31527404
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure-Based Discovery of Pyrimidine Aminobenzene Derivatives as Potent Oral Reversal Agents against P-gp- and BCRP-Mediated Multidrug Resistance.
    Qiu Q; Zou F; Li H; Shi W; Zhou D; Zhang P; Li T; Yin Z; Cai Z; Jiang Y; Huang W; Qian H
    J Med Chem; 2021 May; 64(9):6179-6197. PubMed ID: 33938746
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design, synthesis and bioactivity study on 5-phenylfuran derivatives as potent reversal agents against P-glycoprotein-mediated multidrug resistance in MCF-7/ADR cell.
    Li YS; Yang X; Zhao DS; Cai Y; Huang Z; Wu R; Wang SJ; Liu GJ; Wang J; Bao XZ; Ye XY; Wei B; Cui ZN; Wang H
    Eur J Med Chem; 2021 Apr; 216():113336. PubMed ID: 33725657
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Crizotinib (PF-02341066) reverses multidrug resistance in cancer cells by inhibiting the function of P-glycoprotein.
    Zhou WJ; Zhang X; Cheng C; Wang F; Wang XK; Liang YJ; To KK; Zhou W; Huang HB; Fu LW
    Br J Pharmacol; 2012 Jul; 166(5):1669-83. PubMed ID: 22233293
    [TBL] [Abstract][Full Text] [Related]  

  • 15. N,N-bis(cyclohexanol)amine aryl esters: the discovery of a new class of highly potent inhibitors of transporter-dependent multidrug resistance (MDR).
    Teodori E; Dei S; Martelli C; Scapecchi S
    Curr Top Med Chem; 2010; 10(17):1715-31. PubMed ID: 20645921
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SERCA and P-glycoprotein inhibition and ATP depletion are necessary for celastrol-induced autophagic cell death and collateral sensitivity in multidrug-resistant tumor cells.
    Xu SW; Law BYK; Qu SLQ; Hamdoun S; Chen J; Zhang W; Guo JR; Wu AG; Mok SWF; Zhang DW; Xia C; Sugimoto Y; Efferth T; Liu L; Wong VKW
    Pharmacol Res; 2020 Mar; 153():104660. PubMed ID: 31982489
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discovery and synthesis of 3- and 21-substituted fusidic acid derivatives as reversal agents of P-glycoprotein-mediated multidrug resistance.
    Guo M; Ren Q; Wang B; Ji W; Ni J; Feng Y; Bi Y; Tian J; Wang H
    Eur J Med Chem; 2019 Nov; 182():111668. PubMed ID: 31505451
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glabridin resensitizes p-glycoprotein-overexpressing multidrug-resistant cancer cells to conventional chemotherapeutic agents.
    Qian J; Xia M; Liu W; Li L; Yang J; Mei Y; Meng Q; Xie Y
    Eur J Pharmacol; 2019 Jun; 852():231-243. PubMed ID: 30959046
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and biological evaluation of thiophenylbenzofuran derivatives as potential P-glycoprotein inhibitors.
    Hung CC; Chen CY; Wu YC; Huang CF; Huang YC; Chen YC; Chang CS
    Eur J Med Chem; 2020 Sep; 201():112422. PubMed ID: 32569926
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PD173074, a selective FGFR inhibitor, reverses ABCB1-mediated drug resistance in cancer cells.
    Patel A; Tiwari AK; Chufan EE; Sodani K; Anreddy N; Singh S; Ambudkar SV; Stephani R; Chen ZS
    Cancer Chemother Pharmacol; 2013 Jul; 72(1):189-99. PubMed ID: 23673445
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.